On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. For more information.
On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. For more information.